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Jay Amin hydroxamic acid (JAHA) [1] is a novel metal-based SAHA analogue synthesized in vitro, that shows
significant cytotoxic activity [2] on MDA-M8231 breast cancer cells" To identify protein signatures associated
to its cytotoxic activity, we utilized a proteomic approach to reveal protein expression changes after 1,g, 24
and 48 h of exposure. The protein identification was performed by mass spectrometry, and a total of eleven
differentially-expressed proteins were visualized. Subsequently, Differential Display (DD) gene expression
analysis was used to identify gene signatures in MDA-M8231 human breast cancer cell line after exposure to
JAHA. We found two genes, Rad50 (DNA repair protein) and NTRK2 (neurotrophic tyrosine kinase, receptor,
type 2), upregulated in treated cell preparations, and five genes that encode for protein kinase C epsilon
type, Protein kinase C iota type, Ergic (ER-Golgi intermediated compartiment 2KDa protein), MED25(Mediator of RNA Polymerase ll transcription subunit25) and Brefeldine A-inhibited guanine nucleotide-
exchange protein 3 that were significantly down-regulated after treatment with JAHA.The result obtained by
DD-PCR will be confirmed by Real Time PCR analysis. Further study will be required to compare the reported
signature pattern with that obtained after exposure of MDA-M8231 cells with the parental molecule SAHA,
and to understand the biological implications of the expression changes found.
[1] Spencer et al. (2011) . ACS Med Chem Lett. Z,35g-62.
l2l Librizzi et a l. (20 1 2 ) . Ch e m. R e s. Toxi c o l. ZS, 2608-16.
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Methylation of CpG repeats in the upstream/promoter regions of genes is an established mechanism of gene
silencing in many cell types" DNA methylation results in the recruitment of histone deacetylases (HDACs) to
promoter regions, thereby repressing expression of genes. General inhibitors of class I and ll HDACs (HDAC|),
suppress the growth of cancer cells in vitro and in vivo. ln this study, we investigated the effect of JAHA [1],
a novel HDACi, on the intracellular signaling pathways of MDA-M8231 breast cancer cells" Concerning the
MEK pathwayJAHA repressed MAP kinase (ERK) activation after 18 h until 30 h of the treatment, and also
down-regulated DNA (cytosine-5-)-methyltransferase 1 (DNMT1), a downstream ERK target, already at 1gh
with an increase up to 48 h. To check the occurrence of changes in the extent of global DNA methylation,
genomic DNA was submitted to MeSAP (Methylation Sensitive Restriction Arbitrarily-primed) pCR [2] using
Afa and then Hpall enzymes followed by PCR amplification with an arbitrary primer binding preferentially to
guanine and cytysine (GC)-rich regions of DNA, including CpG islands" preliminary indications suggest the
ability of JAHA to induce hypomethylation patterns in tumoral breast cancer cells after 30 h of the
treatment. Collectively, these data demonstrate that the HDACI JAHA, by inhibiting ERK activity, regulates
DNMTl expression and ultimately DNA methylation"
[1]Spencer J. et al. (2011). ACS Med Chem 1ett.2,358-62.
[2] Naselli F. et al" (2OL4).Gene 535: 29-39
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